What was known before
diabetic macular oedema
DIABETIC MACULAR OEDEMA

Targeted peripheral retinal laser (TPRP) photocoagulation with ranibizumab does not reduce the injection burden for patients with diabetic macular oedema compared to monotherapy ranibizumab.This was demonstrated with an initial intravitreal treatment with 3 monthly loading phase.